Presenting symptoms, severity and clinical outcomes of 113 children with COVID-19 infection on immunosuppressive medication for a kidney disease
| Number of children presenting with each symptom of COVID-19 (%) | 73 fever (65%) 59 cough (52%) 35 rhinitis (31%) 17 diarrhoea (15%) 20 shortness of breath (18%) 21 asymptomatic SARS-CoV-2 infection (19%) |
| Maximal respiratory support required (%) | 5 invasive ventilation (4%) 1 BiPAP (1%) 5 high-flow nasal cannula oxygen (4%) 14 supplemental face mask oxygen (12%) 88 none (78%) |
| Outcome (%) | 4 death (4%) 2 patient on intensive care with recovery (2%) 68 admitted to hospital (60%) 45 not admitted to hospital at any point (40%) |
| Infection severity grade within this study | 45 not admitted to hospital (grade 1) 43 admitted to hospital with no respiratory support (grade 2) 14 admitted to hospital and required supplemental oxygen (grade 3) 5 admitted to hospital and required high-flow nasal cannula oxygen or BiPAP (grade 4) 6 admitted to intensive care or death (grade 5) |
BiPAP, bi-level positive airway pressure.